title: Algorithms using clinical and genetic data (CYP2C9, VKORC1) are relevant to predict warfarin dose in patients with different INR targets.
authors.forename: Véronique
authors.initials: V
authors.lastname: Le Cam-Duchez
authors.forename: Mathilde
authors.initials: M
authors.lastname: Frétigny
authors.forename: Nicole
authors.initials: N
authors.lastname: Cailleux
authors.forename: Catherine
authors.initials: C
authors.lastname: Gandelin
authors.forename: Hervé
authors.initials: H
authors.lastname: Lévesque
authors.forename: Jeanne-Yvonne
authors.initials: JY
authors.lastname: Borg
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000465:Algorithms; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D001777:Blood Coagulation / Q000187:drug effects* / Q000235:genetics; D065729:Cytochrome P-450 CYP2C9; D054796:Drug Dosage Calculations; D016903:Drug Monitoring; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D005602:France; D005838:Genotype; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000235:genetics*; D010597:Pharmacogenetics; D010641:Phenotype; D011110:Polymorphism, Genetic; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin / Q000008:administration & dosage*; D055815:Young Adult
chemical_list: D005343:Fibrinolytic Agents; D014859:Warfarin; D006899:Mixed Function Oxygenases; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; C578523:VKORC1 protein, human; D064417:Vitamin K Epoxide Reductases